Загрузка...
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis
BACKGROUND: Natalizumab (NTZ) is sometimes discontinued in patients with multiple sclerosis, mainly due to concerns about the risk of progressive multifocal leukoencephalopathy. However, NTZ interruption may result in recrudescence of disease activity. OBJECTIVE: The objective of this study was to s...
Сохранить в:
| Опубликовано в: : | Ther Adv Neurol Disord |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6444403/ https://ncbi.nlm.nih.gov/pubmed/30956686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419837809 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|